Open AccessClinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Author(s) -
Alexis LeVee,
Chao Chun Lin,
Edwin M. Posadas,
Robert A. Figlin,
Neil A. Bhowmick,
Dolores Di Vizio,
Leigh Ellis,
Charles J. Rosser,
Michael R. Freeman,
Dan Theodorescu,
Stephen J. Freedland,
Jun Gong
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s343977
Subject(s) - prostate cancer , olaparib , medicine , selection (genetic algorithm) , oncology , gynecology , cancer , poly adp ribose polymerase , machine learning , computer science , biology , biochemistry , polymerase , gene
[This corrects the article DOI: 10.2147/OTT.S315170.].